Global Glaucoma Epidemiology and Patient Flow

Global Glaucoma Epidemiology and Patient Flow Analysis – 2021, provides Glaucoma epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Glaucoma patients, history of the disease at the population level (Glaucoma prevalence, Glaucoma incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

• Glaucoma patient flow: Glaucoma prevalence, diagnosed, and drug-treated patients
• Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
• Demographics: Glaucoma patients by age group, gender
• Forecast: Glaucoma epidemiology forecast to 2030

The data from this research will help executives –

• Establish basis for Glaucoma market sizing, assessing market potential, and developing drug forecast models
• Identify Glaucoma patients segments through age groups, gender, and disease sub-types
• Develop Glaucoma population-based health management frameworks
• Evaluate Glaucoma market opportunities, identify target patient population
• Align marketing decisions with the Glaucoma target population
• Communicate leadership and health authorities about your Glaucoma target patient population